Sean Harper and Stefan Scherer
January 9, 2023 05:00 AM ESTUpdated 08:21 AM
R&D

Bil­lion­aire-backed TCR start­up scores its first mar­quee in­dus­try al­liance

John Carroll

Editor & Founder

SAN FRAN­CIS­CO — A Bay Area start­up out to cre­ate a next-gen play­er in TCRs has just hit a key mile­stone fol­low­ing its re­cent de­but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times